SC
Publicaties op Oncologisch.com
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Gevorderd-Stage Classic Hodg...
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patiënten met Gevorderd-Stage Classic Hodgkin Lymphoma Enrolled...
Nivolumab plus AVD bij gevorderd klassiek hodgkinlymfoom: SWOG S1826 fase III